Skip to content

Drug interactions

Abrocitinib + Ticagrelor

Severity: Major

Abrocitinib and Ticagrelor: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Abrocitinib reduces platelet counts, mainly in the early weeks of treatment, and its labeling advises against antiplatelet drugs other than low-dose aspirin during the first 3 months.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Abrocitinib and Ticagrelor interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level

Free 14-day trial. No card needed.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in